Distinguished in Chiari Malformation

Dr. Andrew E. Sloan

Neurosurgery
Premier Health Specialists Inc
30 E Apple St, Suite 5254a, 
Dayton, OH 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Distinguished in Chiari Malformation
Premier Health Specialists Inc
30 E Apple St, Suite 5254a, 
Dayton, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Andrew Sloan is a Neurosurgery provider in Dayton, Ohio. Dr. Sloan is rated as a Distinguished provider by MediFind in the treatment of Chiari Malformation. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Sloan is currently accepting new patients.

His clinical research consists of co-authoring 186 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurosurgery
Licenses
Neurological Surgery in OH
Hospital Affiliations
Miami Valley Hospital
Languages Spoken
English
Haitian Creole
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

PREMIER HEALTH SPECIALISTS INC
30 E Apple St, Suite 5254a, Dayton, OH 45409

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Phase I/II Study of Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
Phase I/II Study of Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
Enrollment Status: Recruiting
Publish Date: July 02, 2025
Intervention Type: Procedure, Drug
Study Drug: Pembrolizumab
Study Phase: Phase 1/Phase 2
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: September 11, 2025
Intervention Type: Combination product, Procedure, Drug
Study Drugs: IGV-001 Cell Immunotherapy, Temozolomide
Study Phase: Phase 2
Phase II Trial O6-benzylguanine(BG) and Temozolomide(TMZ) Therapy of Glioblastoma Multiforme (GBM) With Infusion of Autologous P140K MGMT+Hematopoietic Progenitors to Protect Hematopoiesis
Phase II Trial O6-benzylguanine(BG) and Temozolomide(TMZ) Therapy of Glioblastoma Multiforme (GBM) With Infusion of Autologous P140K MGMT+Hematopoietic Progenitors to Protect Hematopoiesis
Enrollment Status: Suspended
Publish Date: August 11, 2025
Intervention Type: Radiation, Drug, Biological
Study Drugs: P140K-MGMT, O6-benzylguanine, Temozolomide, Filgrastim, Carmustine
Study Phase: Phase 2
A Multicenter Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (Lerapolturev) in Recurrent WHO Grade IV Malignant Glioma Patients
A Multicenter Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (Lerapolturev) in Recurrent WHO Grade IV Malignant Glioma Patients
Enrollment Status: Completed
Publish Date: July 11, 2025
Intervention Type: Biological, Drug
Study Drug: Oncolytic Polio/Rhinovirus Recombinant Vaccine
Study Phase: Phase 2
A Phase 2, Open-label, Single-arm Study Evaluating the Efficacy, Safety and Tolerability of Lerapolturev (PVSRIPO) and the Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of Patients With Recurrent Glioblastoma
A Phase 2, Open-label, Single-arm Study Evaluating the Efficacy, Safety and Tolerability of Lerapolturev (PVSRIPO) and the Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: June 05, 2025
Intervention Type: Biological
Study Drugs: PVSRIPO, Pembrolizumab
Study Phase: Phase 2
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Enrollment Status: Completed
Publish Date: April 24, 2025
Intervention Type: Device
A Prospective Phase II Trial of NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
A Prospective Phase II Trial of NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: February 17, 2025
Intervention Type: Biological, Device, Other
Study Phase: Phase 2
06-benzylguanine (BG) and Temozolomide (TMZ) Therapy of Glioblastoma Multiforme (GBM) in Patients With MGMT Positive Tumors With Infusion of Autologous P140KMGMT+ Hematopoietic Progenitors to Protect Hematopoiesis
06-benzylguanine (BG) and Temozolomide (TMZ) Therapy of Glioblastoma Multiforme (GBM) in Patients With MGMT Positive Tumors With Infusion of Autologous P140KMGMT+ Hematopoietic Progenitors to Protect Hematopoiesis
Enrollment Status: Completed
Publish Date: March 02, 2023
Intervention Type: Biological, Procedure, Other, Radiation, Drug
Study Drugs: MGMTP140K-encoding retroviral vector, O6-benzylguanine, Temozolomide
Study Phase: Phase 1
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
View 8 Less Clinical Trials

186 Total Publications

Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomas.
Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomas.
Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025
Similar Doctors
Distinguished in Chiari Malformation
Dr. Francesco Mangano
Neurosurgery | Pediatrics
Distinguished in Chiari Malformation
Dr. Francesco Mangano
Neurosurgery | Pediatrics

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (45.0 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances

Francesco Mangano is a Neurosurgery specialist and a Pediatrics provider in Cincinnati, Ohio. Dr. Mangano is rated as an Elite provider by MediFind in the treatment of Chiari Malformation. His top areas of expertise are Hydrocephalus, Epilepsy, Cortical Dysplasia, Posterior Fossa Decompression, and Laminectomy.

Advanced in Chiari Malformation
Dr. Shobhan H. Vachhrajani
Neurosurgery
Advanced in Chiari Malformation
Dr. Shobhan H. Vachhrajani
Neurosurgery

Dayton Childrens Specialty Physicians Inc

1 Childrens Plz, 
Dayton, OH 
 (2.3 miles away)
937-641-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Shobhan Vachhrajani is a Neurosurgery provider in Dayton, Ohio. Dr. Vachhrajani is rated as an Advanced provider by MediFind in the treatment of Chiari Malformation. His top areas of expertise are Chiari Malformation Type 2, Chiari Malformation, Syringomyelia, Posterior Fossa Decompression, and Nerve Decompression. Dr. Vachhrajani is currently accepting new patients.

Distinguished in Chiari Malformation
Dr. Sudhakar Vadivelu
Neurosurgery
Distinguished in Chiari Malformation
Dr. Sudhakar Vadivelu
Neurosurgery

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (45.0 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances

Sudhakar Vadivelu is a Neurosurgery provider in Cincinnati, Ohio. Dr. Vadivelu is rated as a Distinguished provider by MediFind in the treatment of Chiari Malformation. His top areas of expertise are Hydrocephalus, Moyamoya Disease, Chiari Malformation Type 2, Chiari Malformation, and Deep Brain Stimulation.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sloan's expertise for a condition
ConditionClose
View All 15 Distinguished Conditions
View All 9 Advanced Conditions
View All 38 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile